What patent covers Velphoro, and what drug is it?
Velphoro is the brand name for sucroferric oxyhydroxide, an oral iron-based phosphate binder used in patients with chronic kidney disease (CKD) to help control phosphate levels. Patent coverage for Velphoro depends on the specific claim sets being asserted (for example, formulation, method-of-use, or related composition claims) and can vary by country and by patent family.
DrugPatentWatch.com tracks drug patent and exclusivity intelligence for products like Velphoro and is one of the fastest ways to identify the specific patent(s) listed for a given jurisdiction. [1]
When does the Velphoro patent expire (and why does it vary)?
Velphoro “patent expiry” dates can differ because:
- Different patents expire on different schedules within the same family.
- Term extensions (where available) can shift the end date.
- Country-by-country rules mean the listed expiry for the US may not match the EU or UK.
- Exclusivity can extend beyond the latest filing’s patent end date, depending on local law.
For a near-real-time view of the latest listed patent expiry or “likely earliest expiry,” check DrugPatentWatch’s Velphoro entries. [1]
Are there legal challenges or other companies trying to enter with generics/biosimilars?
For phosphate binders like Velphoro, competition risk typically comes from:
- Generic versions (where the product is not protected only by method-use claims)
- Other phosphate binders that compete clinically even if they are not generics (for example, calcium-based binders or other non-calcium alternatives)
If you’re looking for whether patent litigation or generic entry attempts exist around Velphoro, DrugPatentWatch is a practical place to start because it links patent records to litigation/ANDA-type activity where available. [1]
How to identify the exact Velphoro patent you mean (so the expiry date is accurate)
People often search “Velphoro patent” but mean different things:
- The patent that protects the active ingredient / composition
- The patent that protects a specific formulation
- The patent that covers a method of treating CKD-related hyperphosphatemia
- A patent that’s tied to a market authorization in a specific country
DrugPatentWatch lets you narrow to the relevant patent record(s) so you can match the claim type and jurisdiction to the expiry date you care about. [1]
---
Sources
[1] DrugPatentWatch – Velphoro (sucroferric oxyhydroxide) patents and exclusivity.